Department of Neurosurgery, Rush University Medical Center, Chicago, IL, USA.
Interv Neuroradiol. 2024 Oct;30(5):611-618. doi: 10.1177/15910199221097898. Epub 2023 Aug 5.
Several recent reports of CorPath GRX vascular robot (Cordinus Vascular Robotics, Natick, MA) use intracranially suggest feasibility of neuroendovascular application. Further use and development is likely. During this progression it is important to understand endovascular robot feasibility principles established in cardiac and peripheral vascular literature which enabled extension intracranially. Identification and discussion of robotic proof of concept principals from sister disciplines may help guide safe and accountable neuroendovascular application.
Summarize endovascular robotic feasibility principals established in cardiac and peripheral vascular literature relevant to neuroendovascular application.
Searches of PubMed, Scopus and Google Scholar were conducted under PRISMA guidelines using MeSH search terms. Abstracts were uploaded to Covidence citation review (Covidence, Melbourne, AUS) using RIS format. Pertinent articles underwent full text review and findings are presented in narrative and tabular format.
Search terms generated 1642 articles; 177, 265 and 1200 results for PubMed, Scopus and Google Scholar respectively. With duplicates removed, title review identified 176 abstracts. 55 articles were included, 45 from primary review and 10 identified during literature review. As it pertained to endovascular robotic feasibility proof of concept 12 cardiac, 3 peripheral vascular and 5 neuroendovascular studies were identified.
Cardiac and peripheral vascular literature established endovascular robot feasibility and efficacy with equivalent to superior outcomes after short learning curves while reducing radiation exposure >95% for the primary operator. Limitations of cost, lack of haptic integration and coaxial system control continue, but as it stands neuroendovascular robotic implementation is worth continued investigation.
最近有几篇关于 CorPath GRX 血管机器人（Cordinus Vascular Robotics，马萨诸塞州纳蒂克）在颅内使用的报告，表明神经血管应用的可行性。进一步的使用和开发是可能的。在这一进展过程中，了解在心脏和外周血管文献中确立的血管内机器人可行性原则非常重要，这些原则使机器人能够在颅内使用。从姐妹学科中识别和讨论机器人概念验证原则可能有助于指导安全和负责任的神经血管应用。
总结在心脏和外周血管文献中确立的与神经血管应用相关的血管内机器人可行性原则。
根据 PRISMA 指南，使用 MeSH 搜索词在 PubMed、Scopus 和 Google Scholar 上进行了搜索。将摘要以 RIS 格式上传到 Covidence 引文审查（Covidence，墨尔本，AUS）。对相关文章进行全文审查，并以叙述和表格形式呈现研究结果。
搜索词生成了 1642 篇文章；PubMed、Scopus 和 Google Scholar 的结果分别为 177、265 和 1200 篇。去除重复项后，标题审查确定了 176 篇摘要。有 55 篇文章被纳入，其中 45 篇来自主要审查，10 篇是在文献综述中发现的。就血管内机器人可行性概念验证而言，确定了 12 项心脏、3 项外周血管和 5 项神经血管研究。
心脏和外周血管文献确立了血管内机器人的可行性和疗效，在较短的学习曲线后，结果与心脏和外周血管文献相当或更好，同时将主要操作人员的辐射暴露降低了 95%以上。成本、缺乏触觉集成和同轴系统控制的限制仍然存在，但就目前而言，神经血管机器人的实施值得进一步研究。
